According to a report from breastcancer.org, the COVID-19 pandemic has affected just about every aspect of life, including screening, diagnosis, treatment, and follow-up care for breast cancer. October is Breast Cancer Awareness Month and this year it is more important than ever to remind women of the importance of not delaying treatment or screening for detection.
Breast Cancer Awareness: A Potentially Serious Problem
In the American Association of Cancer Research Virtual Meeting: COVID-19 and Cancer on July 22, 2020, researchers from the University of Massachusetts Medical School reported that breast cancer screening decreased dramatically when comparing the same months in 2019 and 2020.
Delays in breast cancer screening can lead to delays in diagnoses. In a June 19 editorial in Science, Dr. Norman Sharpless, director of the National Cancer Institute, said that modeling predicts an excess of 10,000 deaths from breast cancer and colorectal cancer over the next 10 years because of delays in screening procedures during the pandemic.
What Can Be Done?
Adding a health risk assessment (HRA) is a good way to engage women and provide a meaningful outcome and next steps. The Medicom Health Breast Cancer Risk Assessment encourages women to talk to their doctors about breast cancer screening to determine a screening schedule that is right for them.
Placing the HRA on landing pages allows for consumers to better understand their risk, provides education about risk factors, specifihttps://medicomhealth.com/hras/breast-cancer-risk-hra/es appropriate “next steps” and delivers a shareable resource that they may pass along to coworkers, friends or family members.